You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FLT3-MN (SR<0.05)

Showing 1 - 25 of 5,679
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia (AML) Trial in Worldwide (Midostaurin, Midostaurin Placebo, Chemotherapy)

Terminated
  • Acute Myeloid Leukemia (AML)
  • Chicago, Illinois
  • +132 more
Jan 24, 2022

Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +43 more
Nov 17, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-500)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Los Angeles, California
  • +9 more
Jun 27, 2023

Acute Myeloid Leukemia Trial in Wuhan (Fludarabine + Cyclophosphamide + TAA05 Cell Injection)

Recruiting
  • Acute Myeloid Leukemia
  • Fludarabine + Cyclophosphamide + TAA05 Cell Injection
  • Wuhan, Hubei, China
    Wuhan Union Hospital
Jun 29, 2022

FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia Trial in Wuhan (T cell injection targeting FLT3 chimeric antigen

Recruiting
  • FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia
  • T cell injection targeting FLT3 chimeric antigen receptor
  • Wuhan, Hubei, China
    Union Hospital, affiliated with TongJi Medical College, HuaZhong
Jun 20, 2022

Thin-gingiva Trial in Rohtak (microneedling and hyaluronic acid for increasing gingival thickness in thin gingival phenotype,

Not yet recruiting
  • Thin-gingiva
  • microneedling and hyaluronic acid for increasing gingival thickness in thin gingival phenotype
  • microneedling for increasing gingival thickness in thin gingival phenotype
  • Rohtak, Haryana, India
    Post Graduate Institute of Dental Sciences
May 11, 2023

T- and B-Cell Subpopulations in Membranous Nephropathy

Recruiting
  • Membranous Nephropathy
  • +2 more
    • Istanbul, Turkey
      Istanbul University
    May 31, 2023

    Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

    Not yet recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • (no location specified)
    May 24, 2023

    Membranous Nephropathy, Nephrotic Syndrome Trial in Canada, United States (Belimumab, Placebo for Belimumab, Rituximab)

    Recruiting
    • Membranous Nephropathy
    • Nephrotic Syndrome
    • Birmingham, Alabama
    • +16 more
    Sep 22, 2022

    Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

    Recruiting
    • Leukemia, Monocytic, Acute
    • Pediatric AML
    • Foshan, Guangdong, China
    • +8 more
    Mar 28, 2022

    Prognostic Model of TAC in the Treatment of MN

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • (no location specified)
    Dec 28, 2022

    CAR, Acute Myeloid Leukemia Trial in Hefei (TAA05 cell injection)

    Recruiting
    • CAR
    • Acute Myeloid Leukemia
    • TAA05 cell injection
    • Hefei, Anhui, China
      Anhui Provincial Hospital
    Nov 3, 2021

    Idiopathic Membranous Nephropathy Trial (glucocorticoid + tacrolimus)

    Not yet recruiting
    • Idiopathic Membranous Nephropathy
    • glucocorticoid + tacrolimus
    • (no location specified)
    Dec 28, 2022

    Malaria Trial in Kampala (Transfluthrin - delivery by paid study personnel, Transfluthrin - delivery by voucher system,

    Not yet recruiting
    • Malaria
    • Transfluthrin - delivery by paid study personnel
    • +2 more
    • Kampala, Uganda
    • +1 more
    Nov 7, 2023

    Glaucoma, Cataract Trial in Kuala Lumpur (Lignocaine-loaded maltose microneedle array patch, EMLA 5% patch)

    Not yet recruiting
    • Glaucoma
    • Cataract
    • Lignocaine-loaded maltose microneedle array patch
    • EMLA 5% patch
    • Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
      Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia
    Jan 19, 2023

    Thalassemia in Children Trial in Kuala Lumpur (Microneedle, 1 Finger Tip Unit (FTU) EMLA Cream (30-minute application time), 1

    Completed
    • Thalassemia in Children
    • Microneedle
    • +4 more
    • Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
      Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia
    Aug 31, 2022

    Safety and Efficacy Trial in Suzhou (Basiliximab, Vedolizumab)

    Recruiting
    • Safety and Efficacy
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Sep 27, 2023

    Translation and Validation of the COMM and ASI-SR

    Not yet recruiting
    • Opioid Use
    • +3 more
    • Current Opioid Misuse Measure (COMM)-SWE
    • +11 more
    • (no location specified)
    Oct 16, 2023

    Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)

    Not yet recruiting
    • Membranous Nephropathy
    • Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
    • Nice, France
      CHU de NICE
    Jul 4, 2023

    Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (Gilteritinib, Midostaurin)

    Suspended
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome With Excess Blasts-2
    • Adelaide, Australia
    • +193 more
    Jan 5, 2023

    Memory Loss, Alzheimer, Dementia Trial in Minneapolis (PorchLight)

    Active, not recruiting
    • Memory Loss
    • +2 more
    • PorchLight
    • Minneapolis, Minnesota
      University of Minnesota (with Lutheran Social Service of Minneso
    Dec 15, 2022

    Bladder Cancer Trial in Hong Kong (Bipolar transurethral standard resection, Bipolar transurethral en bloc resection)

    Completed
    • Bladder Cancer
    • Bipolar transurethral standard resection
    • Bipolar transurethral en bloc resection
    • Hong Kong, Hong Kong
    • +12 more
    Jun 24, 2022

    HIV Trial in United States (rgp120/HIV-1MN, rgp120/HIV-1 SF-2)

    Completed
    • HIV Infections
    • rgp120/HIV-1MN
    • rgp120/HIV-1 SF-2
    • Birmingham, Alabama
    • +6 more
    Oct 28, 2021

    Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)

    Active, not recruiting
    • Glioblastoma
    • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Nov 16, 2022

    Arbovirus Infections Trial in Colombo, Ragama (Transfluthrin, Placebo)

    Not yet recruiting
    • Arbovirus Infections
    • Transfluthrin
    • Placebo
    • Colombo, West, Sri Lanka
    • +1 more
    Jul 6, 2022